Last 12 months
Inside the activity.
9 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2025 Filed Mar 21, 2025 20:35 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 29,813 | $2.83 | $84,370.79 |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · nonDerivative · entry 3 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046,750 F3 · kind: Represents shares withheld to satisfy tax obligations upon vesting of previously issued restricted stock. F4 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:34 UTC |
Pazdan ChristopherChief Operating Officer
|
Exercise / conversionPerformance Share Unit · Derivative | 36,331 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000114 · form_4.xml · derivative · entry 6 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis. F3 · price: Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis. F5 · derivative.exercise_date: These performance share units were granted on April 24, 2024. Vesting was dependent upon the achievement by Issuer of certain performance criteria as of December 31, 2024. F5 · derivative.expiration_date: These performance share units were granted on April 24, 2024. Vesting was dependent upon the achievement by Issuer of certain performance criteria as of December 31, 2024. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:34 UTC |
Pazdan ChristopherChief Operating Officer
|
Tax withholdingCommon Stock | 12,849 | $2.83 | $36,362.67 |
DisclosureSEC source: 0001161697-25-000114 · form_4.xml · nonDerivative · entry 4 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,625 F2 · kind: Represents shares withheld to satisfy tax obligations upon settlement of vested PSUs. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:34 UTC |
Pazdan ChristopherChief Operating Officer
|
Exercise / conversionCommon Stock | 36,331 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000114 · form_4.xml · nonDerivative · entry 3 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents settlement of vested performance share units ("PSUs") in shares of the Issuer's common stock. F3 · price: Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:35 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · derivative · entry 4 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,904 Underlying: Common Stock · 15,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F5 · price: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F5 · derivative.exercise_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F5 · derivative.expiration_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:35 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 8,848 | $2.89 | $25,546.83 |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · nonDerivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,563 F2 · kind: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units. F4 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:35 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 15,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000116 · form_4.xml · nonDerivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,085,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. F4 · balance_after: Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:34 UTC |
Pazdan ChristopherChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,063 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000114 · form_4.xml · derivative · entry 5 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,192 Underlying: Common Stock · 5,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis. F3 · price: Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis. F4 · derivative.exercise_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F4 · derivative.expiration_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:34 UTC |
Pazdan ChristopherChief Operating Officer
|
Tax withholdingCommon Stock | 1,641 | $2.89 | $4,737.57 |
DisclosureSEC source: 0001161697-25-000114 · form_4.xml · nonDerivative · entry 2 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,143 Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:34 UTC |
Pazdan ChristopherChief Operating Officer
|
Exercise / conversionCommon Stock | 5,063 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000114 · form_4.xml · nonDerivative · entry 1 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units and performance share units are paid out in shares of common stock on a one-for-one basis. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:32 UTC |
Miller Kenneth EChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000112 · form_4.xml · derivative · entry 3 Miller Kenneth E · CIK 0001999516 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,679 Underlying: Common Stock · 5,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date. F3 · price: Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date. F4 · derivative.exercise_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F4 · derivative.expiration_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:32 UTC |
Miller Kenneth EChief Commercial Officer
|
Tax withholdingCommon Stock | 2,168 | $2.89 | $6,259.02 |
DisclosureSEC source: 0001161697-25-000112 · form_4.xml · nonDerivative · entry 2 Miller Kenneth E · CIK 0001999516 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,725 F2 · kind: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:32 UTC |
Miller Kenneth EChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000112 · form_4.xml · nonDerivative · entry 1 Miller Kenneth E · CIK 0001999516 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:30 UTC |
Adams Thomas EdwardChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001161697-25-000110 · form_4.xml · derivative · entry 3 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 5,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date. F3 · price: Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date. F4 · derivative.exercise_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. F4 · derivative.expiration_date: This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:30 UTC |
Adams Thomas EdwardChief Financial Officer
|
Tax withholdingCommon Stock | 1,988 | $2.89 | $5,739.36 |
DisclosureSEC source: 0001161697-25-000110 · form_4.xml · nonDerivative · entry 2 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,416 F2 · kind: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 21, 2025 20:30 UTC |
Adams Thomas EdwardChief Financial Officer
|
Exercise / conversionCommon Stock | 5,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000110 · form_4.xml · nonDerivative · entry 1 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,404 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 21:11 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 16,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000063 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,871,677 F1 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 01:19 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 351,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000059 · form_4.xml · nonDerivative · entry 4 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 517,200 F3 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (3). Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 01:19 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000059 · form_4.xml · nonDerivative · entry 3 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners, LLC Disclosed balance after: 0 F2 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (2). F4 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (4). Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 01:19 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000059 · form_4.xml · nonDerivative · entry 2 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners, LLC Disclosed balance after: 1,000,000 F2 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (2). F4 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (4). Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 01:19 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000059 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 5,887,864 F1 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (1). F4 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (4). Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC |
Matin ShahriarDirector
|
GrantCommon Stock | 3,937 | $3.81 | $14,999.97 |
DisclosureSEC source: 0001161697-25-000021 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,545 Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC |
WHOLIHAN EDWARDDirector
|
GrantCommon Stock | 3,937 | $3.81 | $14,999.97 |
DisclosureSEC source: 0001161697-25-000022 · form_4.xml · nonDerivative · entry 1 WHOLIHAN EDWARD · CIK 0001719764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,713 Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 3,937 | $3.81 | $14,999.97 |
DisclosureSEC source: 0001161697-25-000018 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,556 Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC |
French DonnaDirector
|
GrantCommon Stock | 3,937 | $3.81 | $14,999.97 |
DisclosureSEC source: 0001161697-25-000020 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,915 Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC |
FLETCHER R JOHNDirector · Chairman of the Board
|
GrantCommon Stock | 5,905 | $3.81 | $22,498.05 |
DisclosureSEC source: 0001161697-25-000019 · form_4.xml · nonDerivative · entry 1 FLETCHER R JOHN · CIK 0001215024 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,756 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:17 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GrantCommon Stock | 3,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-25-000017 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 6,887,864 F1 · price: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:06 UTC |
WHOLIHAN EDWARDDirector
|
GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-24-000411 · form_4.xml · nonDerivative · entry 1 WHOLIHAN EDWARD · CIK 0001719764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,776 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:05 UTC |
Matin ShahriarDirector
|
GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-24-000409 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,608 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:05 UTC |
French DonnaDirector
|
GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-24-000407 · form_4.xml · nonDerivative · entry 1 French Donna · CIK 0001863260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,978 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:04 UTC |
FLETCHER R JOHNDirector · Chairman of the Board
|
GrantCommon Stock | 8,181 | $2.75 | $22,497.75 |
DisclosureSEC source: 0001161697-24-000405 · form_4.xml · nonDerivative · entry 1 FLETCHER R JOHN · CIK 0001215024 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,851 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:03 UTC |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-24-000403 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,978 Read SEC document |
| October 01, 2024 Filed Jan 3, 2025 15:08 UTC Amendment |
CASCELLA ROBERTDirector
|
GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-25-000008 · form_4.xml · nonDerivative · entry 1 CASCELLA ROBERT · CIK 0001218713 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,619 Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:02 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GrantCommon Stock | 5,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000401 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 6,883,927 F1 · price: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:35 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
GrantOption to buy Common Stock · Derivative | 140,950 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001161697-24-000399 · form_4.xml · derivative · entry 3 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,950 Underlying: Common Stock · 140,950 shares Expires 2034-08-15 F4 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:35 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 127,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000399 · form_4.xml · derivative · entry 2 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,660 Underlying: Common Stock · 127,660 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. F3 · derivative.expiration_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:35 UTC |
Tharby Linda MDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 63,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000399 · form_4.xml · derivative · entry 1 Tharby Linda M · CIK 0001621797 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,872 Underlying: Common Stock · 63,872 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F2 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F2 · derivative.expiration_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:34 UTC |
Pazdan ChristopherChief Operating Officer
|
GrantOption to buy Common Stock · Derivative | 44,721 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001161697-24-000397 · form_4.xml · derivative · entry 3 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,721 Underlying: Common Stock · 44,721 shares Expires 2034-08-15 F4 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:34 UTC |
Pazdan ChristopherChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 20,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000397 · form_4.xml · derivative · entry 2 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,255 Underlying: Common Stock · 20,255 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. F3 · derivative.expiration_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:34 UTC |
Pazdan ChristopherChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 20,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000397 · form_4.xml · derivative · entry 1 Pazdan Christopher · CIK 0002028813 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,255 Underlying: Common Stock · 20,255 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F2 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F2 · derivative.expiration_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:33 UTC |
Miller Kenneth EChief Commercial Officer
|
GrantOption to buy Common Stock · Derivative | 52,008 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001161697-24-000395 · form_4.xml · derivative · entry 3 Miller Kenneth E · CIK 0001999516 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,008 Underlying: Common Stock · 52,008 shares Expires 2034-08-15 F4 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:33 UTC |
Miller Kenneth EChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 23,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000395 · form_4.xml · derivative · entry 2 Miller Kenneth E · CIK 0001999516 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,574 Underlying: Common Stock · 23,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. F3 · derivative.expiration_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:33 UTC |
Miller Kenneth EChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 23,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000395 · form_4.xml · derivative · entry 1 Miller Kenneth E · CIK 0001999516 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,574 Underlying: Common Stock · 23,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F2 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F2 · derivative.expiration_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:31 UTC |
Adams Thomas EdwardChief Financial Officer
|
GrantOption to buy Common Stock · Derivative | 47,722 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001161697-24-000393 · form_4.xml · derivative · entry 3 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,722 Underlying: Common Stock · 47,722 shares Expires 2034-08-15 F4 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:31 UTC |
Adams Thomas EdwardChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 21,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000393 · form_4.xml · derivative · entry 2 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,617 Underlying: Common Stock · 21,617 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F3 · derivative.exercise_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. F3 · derivative.expiration_date: These restricted stock units will vest based upon the achievement of certain performance conditions as of December 31, 2026. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2026. Read SEC document |
| August 15, 2024 Filed Sep 30, 2024 15:31 UTC |
Adams Thomas EdwardChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 21,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000393 · form_4.xml · derivative · entry 1 Adams Thomas Edward · CIK 0001939226 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,617 Underlying: Common Stock · 21,617 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting. F2 · derivative.exercise_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. F2 · derivative.expiration_date: One-fourth will vest on March 15, 2025 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 20:31 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
OtherCommon Stock | 721,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000316 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 6,878,473 F1 · kind: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 19:13 UTC |
Manko Joseph M. Jr.Director · 10% owner
Horton Capital Management, LLC10% owner
Horton Capital Partners, LLC10% owner
Horton Capital Partners Fund, L.P.10% owner
|
GrantCommon Stock | 5,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-24-000312 · form_4.xml · nonDerivative · entry 1 Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner Horton Capital Management, LLC · CIK 0001575444 · 10% owner Horton Capital Partners, LLC · CIK 0001575443 · 10% owner Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Horton Capital Partners Fund, LP Disclosed balance after: 7,600,254 F1 · price: See Exhibit 99.1 to this Form 4 for explanation of note (1). F2 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (2). Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 14:42 UTC |
WHOLIHAN EDWARDDirector
|
GrantCommon Stock | 5,545 | $2.71 | $15,026.95 |
DisclosureSEC source: 0001161697-24-000310 · form_4.xml · nonDerivative · entry 1 WHOLIHAN EDWARD · CIK 0001719764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,322 Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 14:42 UTC |
Matin ShahriarDirector
|
GrantCommon Stock | 5,545 | $2.71 | $15,026.95 |
DisclosureSEC source: 0001161697-24-000309 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,154 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.